Drug Information

General Information
Drug ID
DR00268
Drug Name
Norepinephrine
Synonyms
(-)-(R)-Norepinephrine; (-)-Arterenol; (-)-Arterenol free base; (-)-NORADRENALINE; (-)-Norepinephrine; (-)-alpha-(Aminomethyl)protocatechuyl alcohol; (R)-(-)-Norepinephrine; (R)-4-(2-Amino-1-hydroxyethyl)-1,2-benzenediol; (R)-Noradrenaline; (R)-Norepinephrine; 1,2-Benzenediol, 4-(2-amino-1-hydroxyethyl)-, (R)-(9CI); 4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol; 4-[(1R)-2-amino-1-hydroxyethyl]benzene-1,2-diol; ALBB-006229; Adrenor; Aktamin; Arterenol; D-(-)-Noradrenaline; D53D5E3A-2360-4CA9-8031-6C2CD4062FD5; L-1-(3,4-Dihydroxyphenyl)-2-aminoethanol; L-2-Amino-1-(3,4-dihydroxyphenyl)ethanol; L-3,4-dihydroxyphenylethanolamine; L-Noradrenaline; L-Norepinephrine; L-alpha-(aminomethyl)-3,4-dihydroxybenzyl alcohol; L-arterenol; LT03330026; LT4; Levarterenol; Levarterenolo; Levarterenolo [DCIT]; Levoarterenol; Levonor; Levonoradrenaline; Levonorepinephrine; Levophed; Nor adrenalin; Nor adrenalin (TN); Noradrenalin; Noradrenalina; Noradrenalina [Italian]; Noradrenaline; Noradrenaline (JP15); Noradrenalinum; Noreinefrina; Noreinefrina [INN-Spanish]; Norepinefrina; Norepinephrine (INN); Norepinephrine Noradrenalin; Norepinephrine [INN:JAN]; Norepinephrine l-Tartrate (1:1); Norepinephrinum; Norepinephrinum [INN-Latin]; Norepirenamine; Sympathin E
Drug Type
Small molecular drug
Indication Neurogenic shock [ICD11: MG40.Y] Approved [1]
Septic shock [ICD11: 1G41] Approved [1]
Therapeutic Class
Vasoconstrictor Agents
Structure
3D MOL 2D MOL
Formula
C8H11NO3
Canonical SMILES
C1=CC(=C(C=C1C(CN)O)O)O
InChI
InChI=1S/C8H11NO3/c9-4-8(12)5-1-2-6(10)7(11)3-5/h1-3,8,10-12H,4,9H2/t8-/m0/s1
InChIKey
SFLSHLFXELFNJZ-QMMMGPOBSA-N
CAS Number
CAS 51-41-2
Pharmaceutical Properties Molecular Weight 169.18 Topological Polar Surface Area 86.7
Heavy Atom Count 12 Rotatable Bond Count 2
Hydrogen Bond Donor Count 4 Hydrogen Bond Acceptor Count 4
XLogP
-1.2
PubChem CID
439260
PubChem SID
10298272 , 11335405 , 11360644 , 11363903 , 11366465 , 11369027 , 11371679 , 11373774 , 11377189 , 11461616 , 11484784 , 11488880 , 11490336 , 11491893 , 11494823 , 15898897 , 22426371 , 24714977 , 24891196 , 26512253 , 26611841 , 26679364 , 26683762 , 26754493 , 26754494 , 29215339 , 36883508 , 3828 , 46394455 , 46506201 , 47291023 , 47662149 , 47959614 , 48034990 , 48259106 , 48416337 , 49892614 , 50109852 , 50109853 , 51036046 , 53788371 , 56311831 , 56313397 , 57288371 , 7847144 , 7980168 , 8144526 , 8149447 , 840952 , 841792
ChEBI ID
ChEBI:18357
TTD Drug ID
D07MOX
DT(s) Transporting This Drug GLYT2 Transporter Info Sodium- and chloride-dependent glycine transporter 2 Substrate [2]
NET Transporter Info Sodium-dependent noradrenaline transporter Substrate [3]
OCT-1 Transporter Info Organic cation transporter 1 Substrate [4]
OCT-2 Transporter Info Organic cation transporter 2 Substrate [5]
OCT-3 Transporter Info Organic cation transporter 3 Substrate [5]
VMAT1 Transporter Info Vesicular amine transporter 1 Substrate [6]
VMAT2 Transporter Info Vesicular amine transporter 2 Substrate [6]
Drug-Transporter Activity Data
Drug-Transporter Activity Data NET Transporter Info Km = 690 microM Monkey kidney fibroblast-like cell (COS)1-NET [7]
OCT-2 Transporter Info Km = 1500 microM Human embryonic kidney cells (HEK293)-OCT2 [5]
OCT-2 Transporter Info Km = 1900 microM Oocytes-OCT2 [8]
OCT-3 Transporter Info Km = 510 microM Human embryonic kidney cells (HEK293)-OCT3 [9]
OCT-3 Transporter Info Km = 2630 microM Human embryonic kidney cells (HEK293)-OCT3 [5]
References
1 Norepinephrine was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019)
2 SLC6A2 Gene (Protein Coding).
3 Chronic depolarization stimulates norepinephrine transporter expression via catecholamines. J Neurochem. 2006 May;97(4):1044-51.
4 Organic cation transporters and their pharmacokinetic and pharmacodynamic consequences. Drug Metab Pharmacokinet. 2008;23(4):243-53.
5 Differential pharmacological in vitro properties of organic cation transporters and regional distribution in rat brain. Neuropharmacology. 2006 Jun;50(8):941-52.
6 SLC18: Vesicular neurotransmitter transporters for monoamines and acetylcholine. Mol Aspects Med. 2013 Apr-Jun;34(2-3):360-72.
7 chi-Conotoxin and tricyclic antidepressant interactions at the norepinephrine transporter define a new transporter model. J Biol Chem. 2007 Jun 15;282(24):17837-44.
8 Human neurons express the polyspecific cation transporter hOCT2, which translocates monoamine neurotransmitters, amantadine, and memantine. Mol Pharmacol. 1998 Aug;54(2):342-52.
9 Molecular identification of the corticosterone-sensitive extraneuronal catecholamine transporter. Nat Neurosci. 1998 Sep;1(5):349-51.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.